Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80
Document › Details

PathoQuest S.A.S.. (10/31/18). "Press Release: PathoQuest Achieves Illumina Propel Certification".

Organisations Organisation PathoQuest S.A.S.
  Organisation 2 Illumina Inc. (Nasdaq: ILMN)
  Group Illumina (Group)
Products Product NexSeq System
  Product 2 DNA sequencing service
     


PathoQuest is pleased to announce that it has received Propel Certification from Illumina after successfully completing the requirements for achieving this recognition. This included demonstrating the ability to produce high-quality data on the NexSeq System following a streamlined and rigorous process. PathoQuest’s Propel Certification is valid for the company’s Biologics Genomic Service projects which utilize Illumina’s NGS library preparation and sequencing protocols.

Propel Certification enables our customers to feel confident that they are receiving the highest quality data, insight, and service when PathoQuest utilizes Illumina’s technology for projects.


   
Record changed: 2019-01-14

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for PathoQuest S.A.S.


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Hotspot for Startups 650x80px




» top